High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT.

Tzu-Ju ChenChia-Lin ChouYu-Feng TianCheng-Fa YehTi-Chun ChanHong-Lin HeWan-Shan LiHsin-Hwa TsaiChien-Feng LiHong-Yue Lai

Published in: International journal of clinical oncology (2021)

These results suggest that high FRMD3 expression is related to advanced clinicopathological features and inferior therapeutic responses in rectal cancer patients treated with CCRT, validating the promising prognostic value of FRMD3 expression.

Keyphrases

rectal cancer
poor prognosis
locally advanced
binding protein
long non coding rna
squamous cell carcinoma
radiation therapy
free survival